Search results
Actinium Announces Multiple Abstracts Highlighting its Antibody Radiation Conjugates Iomab-B and...
WJTV Jackson· 13 hours agoIomab-B and Actimab-A are the only targeted radiotherapies in development for patients with relapsed/refractory acute myeloid leukemia
Earnings call: Moleculin Biotech optimistic on Annamycin's future By Investing.com
Investing.com· 2 hours agoThe company has secured a composition of matter patent for Annamycin, ensuring market exclusivity...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 45 minutes agoHONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a registrational Phase III clinical trial of HMPL-306
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival:...
Medical Xpress· 4 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 5 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
2 Incredible Growth Stocks to Buy Hand Over Fist
Motley Fool via Yahoo Finance· 6 days agoThis novel oral treatment for leukemia has the potential to surpass $1 billion in sales if it secures regulatory nods in both the front- and later-line...
Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show
MedPage Today· 5 days agoVenetoclax (Venclexta) combined with a hypomethylating agent (HMA) -- the standard of care for older...
Obituary - Steven Michael Kakuska
Fontana Herald News· 3 days agoSteven Michael Kakuska’s battle with acute myeloid leukemia ended on Saturday, March 27, when he passed away at Kaiser Hospital in Fontana ...
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
FOX 23 News Albany· 14 hours agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Bergen Record via Yahoo News· 5 days agoIt is now a life purpose for Paula Corrieri, of Wayne, whose 15-year-old son, Rocco Sivolella, died...
